We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+2.25%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$203M
AUM Growth
+$6.95M
Cap. Flow
+$3.45M
Cap. Flow %
1.7%
Top 10 Hldgs %
24.55%
Holding
99
New
4
Increased
34
Reduced
35
Closed
2

Top Buys

Rank Stock Value
1
GIS icon
General Mills
GIS
+$2.77M
2
IBB icon
iShares Biotechnology ETF
IBB
+$356K
3
CL icon
Colgate-Palmolive
CL
+$345K
4
CVS icon
CVS Health
CVS
+$285K
5
GE icon
GE Aerospace
GE
+$272K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$618K
2
MA icon
Mastercard
MA
+$472K
3
BBH icon
VanEck Biotech ETF
BBH
+$315K
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$228K
5
CLX icon
Clorox
CLX
+$212K

Sector Composition

Rank Sector Weight
1 Technology 14.43%
2 Industrials 13.17%
3 Healthcare 12.14%
4 Financials 10.95%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
76
Oracle
ORCL
$349B
$419K 0.21%
9,510
– –
LLY icon
77
Eli Lilly
LLY
$1.09T
$383K 0.19%
4,500
-315
-7% -$25.9K
PPG icon
78
PPG Industries
PPG
$25.1B
$383K 0.19%
3,700
– –
ITW icon
79
Illinois Tool Works
ITW
$84.1B
$357K 0.18%
2,580
– –
EMR icon
80
Emerson Electric
EMR
$82.9B
$352K 0.17%
5,100
-680
-12% -$47.8K
YUM icon
81
Yum! Brands
YUM
$42.1B
$349K 0.17%
4,468
– –
AMLP icon
82
Alerian MLP ETF
AMLP
$12.9B
$346K 0.17%
6,863
-142
-2% -$7.2K
DD icon
83
DuPont de Nemours
DD
$18.9B
$336K 0.17%
2,015
– –
KMB icon
84
Kimberly-Clark
KMB
$37.5B
$335K 0.16%
3,185
-590
-16% -$61.3K
WFC icon
85
Wells Fargo
WFC
$257B
$316K 0.16%
5,705
– –
WM icon
86
Waste Management
WM
$95.4B
$291K 0.14%
3,580
– –
MNDT
87
DELISTED
Mandiant, Inc. Common Stock
MNDT
$290K 0.14%
18,900
– –
VFC icon
88
VF Corp
VFC
$5.87B
$254K 0.13%
3,313
-362
-10% -$27.3K
OXY icon
89
Occidental Petroleum
OXY
$55.7B
$249K 0.12%
+2,980
New +$238K
AMGN icon
90
Amgen
AMGN
$210B
$247K 0.12%
1,340
+160
+14% +$28.3K
DHR icon
91
Danaher
DHR
$139B
$238K 0.12%
2,726
– –
TXN icon
92
Texas Instruments
TXN
$256B
$227K 0.11%
2,060
– –
IJH icon
93
iShares Core S&P Mid-Cap ETF
IJH
$123B
$223K 0.11%
+5,735
New +$222K
GPC icon
94
Genuine Parts
GPC
$18B
$219K 0.11%
2,390
– –
SO icon
95
Southern Company
SO
$108B
$218K 0.11%
4,710
-740
-14% -$33.1K
MRSH
96
Marsh
MRSH
$94.2B
$214K 0.11%
2,620
– –
HPQ icon
97
HP
HPQ
$26.6B
$201K 0.1%
+8,880
New +$198K
CLX icon
98
Clorox
CLX
$12.1B
– –
-1,595
Closed -$212K
EFA icon
99
iShares MSCI EAFE ETF
EFA
$77.4B
– –
-3,286
Closed -$228K
1 2 3
4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
GPA
Guidance Point Advisors Wellesley, Massachusetts $422M AUM 16.47% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return

Boston Research & Management's Q2 2018 Portfolio in Review

As of Q2 2018, Boston Research & Management held 99 positions worth $203M, up 3.5% from $196M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boston Research & Management's Q2 2018 filing shows 4 new, 34 increased, 35 reduced and 2 closed positions. Its largest new stake was General Mills: 63,350 shares worth $2.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $618K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management's largest Q2 2018 buy was General Mills: 63,350 shares worth $2.8M.
  • Boston Research & Management added most to iShares Biotechnology ETF in Q2 2018, an estimated $356K increase.
  • Boston Research & Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $618K.
  • Boston Research & Management fully exited iShares MSCI EAFE ETF in Q2 2018, selling an estimated $228K.
  • Boston Research & Management's ten largest holdings make up 25% of its $203M portfolio in Q2 2018.
  • Boston Research & Management opened 4 new positions and closed 2 in Q2 2018.
  • Boston Research & Management's portfolio value rose 3.5% quarter-over-quarter to $203M.

Based on Boston Research & Management's 13F filing for Q2 2018, filed 30 Jul 2018.